This department is offering the ‘Collaborative Clinical Trials in Drug Abuse (R01)’ grant to promote collaboration among investigators at different sites to address critical issues in treating substance-related disorders. The grant aims to fund Research Project Grant (R01) applications from institutions/organizations proposing common clinical trials with a coordinating site and collaborating sites. The National Institute on Drug Abuse (NIDA) seeks to study patient outcomes, provider factors, and other effects with pooled samples to achieve sample sizes greater than what a single site can attain. The grant will be awarded through the NIH Research Project Grant (R01) mechanism.
Opportunity ID: 43898
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-07-232 |
| Funding Opportunity Title: | Collaborative Clinical Trials in Drug Abuse (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 05, 2008 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – Multiple Receipt Dates – See Link to Full Announcement for details. |
| Current Closing Date for Applications: | – Multiple Receipt Dates – See Link to Full Announcement for details. |
| Archive Date: | Feb 02, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) County governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Private institutions of higher education Independent school districts State governments Public and State controlled institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses |
| Additional Information on Eligibility: | Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse, National Institutes of Health, is a reissuance of PAR-04-073, Collaborative Clinical Trials in Drug Abuse, published in the NIH Guide for Contracts and Grants, March 9, 2004 at http://grants.nih.gov/grants/guide/pa-files/PAR-04-073.html. This announcement provides guidelines for the development, review, and funding of Collaborative Clinical Trials in Drug Abuse (CCTDA) through the solicitation of Research Project Grant (R01) applications from institutions/organizations that propose to carry out clinical trials using a common protocol at collaborating sites. One of the sites should be the coordinating site for the trial. Each site must submit a separate R01 application. Although a foreign institution may be a participating site, the coordinating site must be a domestic institution. -Purpose. The National Institute on Drug Abuse (NIDA) seeks to increase the collaboration of investigators at different sites in order to address critical issues in the treatment of substance-related disorders that require sample sizes greater than a single site can reasonably attain. The expectation for the collaborative effort is that there will be implementation of common clinical trials across different sites in order to study patient outcomes, patient factors, provider factors, setting characteristics, interactions of these, or other effects where pooled samples are appropriate and necessary for the hypotheses under consideration. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-07-232.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | ADOBE-FORMS-A | Adobe-Forms-A | PKG00009246 | Dec 05, 2008 | Jan 07, 2010 | View |
Package 1
Mandatory forms
43898 RR_SF424-1.1.pdf
43898 RR_KeyPersonExpanded-1.1.pdf
43898 RR_OtherProjectInfo-1.1.pdf
43898 RR_PerformanceSite-1.1.pdf
43898 PHS398_CoverPageSupplement-1.1.pdf
43898 PHS398_ResearchPlan-1.1.pdf
43898 PHS398_Checklist-1.1.pdf
Optional forms
43898 PHS398_CoverLetter-1.1.pdf
43898 PHS398_ModularBudget-1.1.pdf
43898 RR_Budget-1.1.pdf
43898 RR_SubawardBudget-1.2.pdf
Leave a Reply